Bausch Health Companies Inc.
BHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $912 | $2,530 | $2,259 | $2,559 |
| % Growth | -64% | 12% | -11.7% | – |
| Cost of Goods Sold | -$668 | $764 | $701 | $727 |
| Gross Profit | $1,580 | $1,766 | $1,558 | $1,832 |
| % Margin | 173.2% | 69.8% | 69% | 71.6% |
| R&D Expenses | $166 | $160 | $171 | $163 |
| G&A Expenses | $0 | $0 | $0 | $30 |
| SG&A Expenses | $795 | $894 | $862 | $816 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $786 |
| Other Operating Expenses | $0 | $268 | $249 | $295 |
| Operating Expenses | $961 | $1,322 | $1,282 | $1,274 |
| Operating Income | $619 | $444 | $276 | $558 |
| % Margin | 67.9% | 17.5% | 12.2% | 21.8% |
| Other Income/Exp. Net | -$401 | -$304 | -$323 | -$349 |
| Pre-Tax Income | $218 | $140 | -$47 | $209 |
| Tax Expense | $39 | $12 | $39 | $111 |
| Net Income | $179 | $148 | -$58 | $93 |
| % Margin | 19.6% | 5.8% | -2.6% | 3.6% |
| EPS | -0.24 | 0.4 | -0.16 | 0.25 |
| % Growth | -160% | 350% | -164% | – |
| EPS Diluted | -0.24 | 0.4 | -0.16 | 0.25 |
| Weighted Avg Shares Out | 371 | 371 | 363 | 372 |
| Weighted Avg Shares Out Dil | 373 | 373 | 363 | 372 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15 | $13 | $11 | $9 |
| Interest Expense | $2,002 | $465 | $330 | $337 |
| Depreciation & Amortization | $300 | $307 | $305 | $307 |
| EBITDA | $2,520 | $764 | $602 | $901 |
| % Margin | 276.3% | 30.2% | 26.6% | 35.2% |